Publisher
Springer Berlin Heidelberg
Reference65 articles.
1. Altamura AC, Curry SH, Montgomery S, Wiles DH (1985) Early unwanted effects of fluphenazine esters related to plasma fluphenazine concentrations in schizophrenic patients. Psychopharmacology 87:30–33
2. Aschauer H, Resch F (1983) Praxisnahe Übersicht der Psychopharmaka mit Verzeichnis der Präparate. In: Langer G, Heimann H (Hrsg) Psychopharmaka. Grundlagen und Therapie. Springer, Wien New York, S 663–730
3. Baldessarini RJ, Davis JM (1980) What is the best maintenance dose of neuroleptics in schizophrenia? Psychiatry Res 3:115–122
4. Baldessarini RJ, Cohen BM, Teicher MH (1988) Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry 45:79–91
5. Bolvig Hansen L, Larsen NE (1985) Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice. Psychopharmacology 87:16–19